-
The highest drop is over 90%!
Time of Update: 2021-09-03
Calculation of the reduction in the results of the planned selection of the 2021 centralized drug procurement of the Gansu-Shaanxi Alliance
-
Tan Desai calls for a two-month suspension of immunization of the new crown vaccine
Time of Update: 2021-09-03
. Tan Desai called on countries preparing for the booster shot to share the vaccine with other countries to increase the coverage of their first and second doses of vaccine .
-
WHO: A total of 213,050,725 confirmed cases of new crowns worldwide
Time of Update: 2021-09-03
WHO: The global cumulative number of confirmed cases of new crown reached 213,050,725 WHO: The global cumulative number of confirmed cases of new crown reached 213,050,725 WHO: The
-
How to explain the wear and tear of spine cushion
Time of Update: 2021-09-03
" Liu Peng believes that more importantly, this research has identified a new group of nucleus pulposus progenitor cells (NPPC) from the transcriptome and functional level.
-
21 new confirmed cases on August 22 were all imported from abroad
Time of Update: 2021-09-03
As of 24:00 on August 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 1,695 confirmed cases (including 23 severe cases), a total of 88,321 cured and discharged cases, and a total of 4,636 deaths.
-
Exclusive interview with CDE director Kong Fanpu: Innovative drug review set a new record, and the international drug review track accelerated
Time of Update: 2021-09-03
With the year-on-year increase in the number of drug registration application tasks and the high technical content of the declared varieties, the overall completion rate of the innovative drug-related tasks of the Center for Drug Evaluation exceeded 90% within the time limit .
-
Lu Shibi: When the people are in trouble, of course they must be at the forefront
Time of Update: 2021-09-03
Lu Shibi: When the people are in trouble, of course they must be at the forefront In the General Hospital of the Chinese People's Liberation Army, the paging system is the "general dispatch".
-
Russia has developed a new method of targeted cancer therapy
Time of Update: 2021-09-03
From the Tomsk Polytechnic University, the Russian Academy of Sciences Shemya gold and Ovchinnikov Institute of Organic Chemistry and Biological Russian Academy of Sciences, Tomsk National Research Medical Center research team composed of the development of drug forms for personalized treatment of substance , Especially found the radionuclide for target imaging for the treatment of tumor diseases .
-
CDE Yang Zhimin, Xie Songmei: Drug review promotes the development of pediatric drugs through multiple channels, and product reviews are gradually increasing!
Time of Update: 2021-09-03
Recently, a reporter from the "Pharmaceutical Economic News" learned from the National Medical Products Administration that in recent years, in order to solve the problem of difficult drug development for children, the drug review and approval agency has launched a series of encouraging research and development innovation, improving review efficiency, and improving work > .
-
my country's inactivated vaccine is effective against Delta, with a total protection rate of 59%
Time of Update: 2021-09-03
The above real-world studies show that the overall protection rate of the two domestic inactivated vaccines in China is 59%, the protection effect for the prevention of moderate new coronary pneumonia can reach 70.
-
There is a "door" for the new coronavirus to infect human cells
Time of Update: 2021-09-03
However, in the latest research, a team of scientists led by Romney Amaro, a biophysical chemist at the University of California, San Diego, used supercomputing simulations and found that these "glycan gates" would change from one state (closed) to Another state (open) .
-
New crown and influenza combined detection "two-in-one" kit was approved for marketing
Time of Update: 2021-09-03
With the support of the Shanghai Municipal Science and Technology Commission, the "New Coronavirus 2019-nCoV and Influenza A and B Virus Nucleic Acid Combined Detection Kit (Fluorescence PCR Method)" developed and produced by Shanghai Silide Biomedical Technology Co.
-
Health Commission: 32 new cases were diagnosed on the 21st, of which 4 were in the local area
Time of Update: 2021-09-03
As of 24:00 on August 21, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1748 confirmed cases (including 30 severe cases), a total of 88247 cured and discharged cases, and a total of 4636 deaths.
-
Shanghai Pharmaceuticals: Metronidazole tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-08-30
On June 25, Shanghai Pharmaceuticals announced that Xinyi Wanxiang, a subsidiary of the company, received the "Drug Supplementary Application Approval Notice" issued by the State Drug Administration for metronidazole tablets.
-
Yiling Pharmaceutical: Lianhua Qingwen Capsules Obtained Ukrainian Drug Registration Approval
Time of Update: 2021-08-30
Lianhua Qingwen products are the company’s leading products, the National Essential Drug List and the National Medical Insurance List (Class A), and are mainly used for the treatment of colds and flu-related diseases .
-
Liu Lei, director and executive vice president of Lanhai Medical, resigns
Time of Update: 2021-08-30
On June 22, Lanhai Medical announced that it had recently received a written resignation report from the company’s director and executive vice president, Ms.
Lanhai Medical will nominate suitable director candidates in a timely manner in accordance with relevant regulations and submit them to the general meeting of shareholders for approval .
-
Many foreign companies’ products are on the list. Another batch of generic drug reference preparation catalogues has been released!
Time of Update: 2021-08-30
Are you familiar?List of generic reference preparations (42nd batch)1.
of the varieties listed in the catalog that have not yet been marketed in China shall be subject to the approval of the Pharmacopoeia Commission .
-
Only 27 million imatinib was sold
Time of Update: 2021-08-30
Shanghai Modern Pharmaceutical stated that after the signing of this contract, Sinopharm Yixin still needs to complete the change of the relevant preparation marketing license holder, and will implement the transfer of raw material technology and the change of preparation production address.
-
Hanguang Pharmaceutical Nitisinone Approved to Treat Type 1 Tyrosinemia Patients
Time of Update: 2021-08-30
The approval of Niticinone capsules declared by Hanguang Pharmaceuticals means that Chinese patients with type 1 tyrosinemia have ushered in the first therapeutic drug .
-
Watson Bio: Subsidiary's 23-valent pneumococcal polysaccharide vaccine increases vial packaging approved
Time of Update: 2021-08-30
After obtaining the "Drug Supplementary Application Approval Notice" this time, Yuxi Watson's 23-valent pneumococcal polysaccharide vaccine will be At the same time, it has two dosage forms: "prefilled syringe" packaging and "cillin bottle" packaging .
